All Pathways
Cardiothoracic SurgeryEmergency

Esophageal Perforation / Boerhaave Syndrome (WSES 2019)

Esophageal Perforation / Boerhaave Syndrome (WSES 2019): Suspected Esophageal Perforation → Clinical Recognition → Diagnostic Workup (WSES Level I) → Id...

Pathway Overview

12 steps

Algorithm Steps

12 total

  1. 01Start

    Suspected Esophageal Perforation

    Chest/epigastric pain after vomiting, endoscopy, or foreign body

  2. 02Action

    Clinical Recognition

    Mackler Triad and other signs

    • MACKLER TRIAD:
    • • Vomiting
    • • Chest pain
    • • Subcutaneous emphysema
    • Other signs: fever, dysphagia, odynophagia
    • Hamman sign (mediastinal crunch)
    • Pleural effusion (often left-sided)
  3. 03Action

    Diagnostic Workup (WSES Level I)

    Confirm diagnosis and localize perforation

    • Labs: CBC, BMP, lactate, CRP (WSES Level I)
    • Imaging sequence:
    • 1. CXR: pneumomediastinum, pleural effusion, hydropneumothorax
    • 2. Water-soluble contrast swallow (Gastrografin)
    • 3. CT chest/abdomen with oral contrast (most sensitive)
    • CT sensitivity >90% for perforation
  4. 04Action

    Identify Etiology

    Guides management approach

    • SPONTANEOUS (Boerhaave): 15%
    • • Post-vomiting, large tear (3-8cm)
    • • Usually left lower esophagus
    • IATROGENIC: 60%
    • • Endoscopy, dilation, TEE
    • • Often smaller, better contained
    • TRAUMA/FOREIGN BODY: 25%
  5. 05Decision

    Management Approach?

    Based on clinical status and leak containment

    • CONSERVATIVE criteria (all must be met):
    • • Well-contained leak (no mediastinal soiling)
    • • Drains back into esophagus
    • • Minimal symptoms
    • • No sepsis
  6. 06Action

    Conservative Management

    For contained perforations, minimal contamination

    • NPO, NG tube
    • Broad-spectrum IV antibiotics
    • Antifungals (consider)
    • PPI therapy
    • TPN for nutrition
    • Serial imaging to confirm healing
    • Consider endoscopic stent if:
    • • Small contained perforation
    • • No sepsis
  7. 07Action

    Endoscopic Options

    Emerging alternatives

    • Self-expanding stents (SEMS):
    • • Bridge to healing or surgery
    • • Best for contained leaks
    • Endoscopic vacuum therapy (EVT):
    • • Newer technique, promising results
    • • Multicenter data emerging (2025)
    • Clips/over-the-scope clips (OTSC):
    • • Small acute perforations
  8. 08Action

    ICU Care & Monitoring

    Ongoing management

    • Sepsis management
    • Nutrition (TPN → enteral via J-tube)
    • Repeat imaging in 5-7 days
    • Contrast swallow before oral intake
    • Watch for: empyema, abscess, fistula
  9. 09Outcome

    Healed / Reconstructed

    Long-term: stricture surveillance

  10. Path rejoins step 08Shared downstream outcome
  11. 10Action

    Surgical Intervention

    For uncontained leaks, sepsis, or failed conservative

    • TIMING CRITICAL:
    • • <24h: primary repair possible
    • • >24h: tissue friable, drainage/diversion
    • Approach: left thoracotomy (distal)
    • or right thoracotomy (mid/proximal)
  12. 11Action

    Surgical Options

    Based on tissue quality and timing

    • PRIMARY REPAIR (<24h, healthy tissue):
    • • Debride edges, 2-layer closure
    • • Buttress with pleural/intercostal flap
    • • Wide drainage
    • DRAINAGE ONLY (>24h or septic):
    • • Decortication, drain mediastinum
    • • Consider T-tube
    • DIVERSION (severe contamination):
    • • Cervical esophagostomy
    • • Gastrostomy + feeding jejunostomy
    • • Delayed reconstruction
  13. Path rejoins step 08Shared downstream outcome
  14. Path rejoins step 10Shared downstream outcome
  15. 12Warning

    ⚠️ TIME IS CRITICAL

    Mortality: <24h = 10-25%, >24h = 40-60%, untreated = nearly 100%

Guideline Source

WSES Guidelines on Esophageal Emergencies

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Mortality 60% if delayed diagnosis, nearly 100% untreated
  • Optimal management depends on time to diagnosis
  • Endoscopic stenting role still evolving
  • Decision to repair vs drain vs divert depends on tissue quality

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Esophageal Perforation / Boerhaave Syndrome (WSES 2019)?

The Esophageal Perforation / Boerhaave Syndrome (WSES 2019) is a emergency clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on WSES Guidelines on Esophageal Emergencies.

What guideline is the Esophageal Perforation / Boerhaave Syndrome (WSES 2019) based on?

This algorithm is based on WSES Guidelines on Esophageal Emergencies (DOI: 10.1186/s13017-019-0245-2).

What are the limitations of the Esophageal Perforation / Boerhaave Syndrome (WSES 2019)?

Known limitations include: Mortality 60% if delayed diagnosis, nearly 100% untreated; Optimal management depends on time to diagnosis; Endoscopic stenting role still evolving; Decision to repair vs drain vs divert depends on tissue quality. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Esophageal Perforation / Boerhaave Syndrome (WSES 2019) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free